9
V.19 REGISTER ONLINE cumming.ucalgary.ca/cme PAPERLESS CONFERENCE Access to handouts will be available prior to conference ON-SITE REGISTRATION Based on availability, is not guaranteed and a surcharge may be applied Check the website for any program updates cumming.ucalgary.ca/cme/courses ACCOMMODATION Registrants must make their own accommodation arrangements. Hotel(s) close to the University/course venue include: Hotel Alma 169 University Gate NW Calgary, AB T2N 1N4 Phone 403.220.2588 Toll Free 1.877.498.3203 Email [email protected] hotelalma.ca To obtain a University rate, please indicate the promotion code UOFC and show your CME&PD course confirmation/receipt upon arrival. COURSE OVERVIEW This course provides evidence-based information about the pharmacology, methods of ingestion, adverse effects across the lifespan, medical uses of cannabis and effects on driving. Participants will learn about the diagnosis and treatment of medical emergencies involving cannabis and how to screen patients for cannabis use and for cannabis use disorder. Also covered are how to determine whether patients have contraindications for cannabis use, and the process for authorizing cannabis for medical purposes in appropriate patients. COURSE OBJECTIVES At the end of this course, learners will be equipped to: summarize basic information about the pharmacology, methods of ingestion and adverse effects of cannabis and its analogues discuss the evidence supporting the use of cannabis for medical purposes describe the types of cannabis related medical emergencies and their treatment • discuss the effects of cannabis on driving • discuss the effects of cannabis throughout the life span • counsel patients on cannabis use • screen patients for cannabis use disorder and identify appropriate treatment discuss Alberta Health Services policies around cannabis use in hospital and homecare settings WHO SHOULD ATTEND Physicians, Pharmacists, Nurse Practitioners, Registered Nurses, Psychologists, Social Workers, Other Health Professionals, Residents and Trainees CREDITS Mainpro+ Group Learning – 6.75 credits | MOC Section 1 – 6.75 hours The Canadian Council on Continuing Education in Pharmacy has accredited this program for 6.91 CEUs. Pharmacists Program Number: 1180-2018-2635-C-P, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Pharmacy Technicians Program Number: 1180-2018- 2636-C-T, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Practical Skills for Working with Patients Around Cannabis CALGARY THERAPEUTICS PRE-COURSE CANNABIS UPDATE 2019 Wednesday, April 24, 2019 Red & White Club, 1833 Crowchild Trail NW, Calgary, AB cumming.ucalgary.ca/cme CANNABIS UPDATE 2019 | PAGE 1 OF 9 CUMMING SCHOOL OF MEDICINE Office of Continuing Medical Education and Professional Development

CANNABIS UPDATE 2019 Pharmacist, Calgary Co-op, Calgary Marsha Kucera MD CCFP Clinical Lecturer, Cumming School of Medicine, University of Calgary; Family Physician, Sunridge Medical

Embed Size (px)

Citation preview

V.19

REGISTER ONLINE cumming.ucalgary.ca/cme

PAPERLESS CONFERENCE Access to handouts will be available prior to conference

ON-SITE REGISTRATION Based on availability, is not guaranteed and a surcharge may be applied

Check the website for any program updates cumming.ucalgary.ca/cme/courses

ACCOMMODATION

Registrants must make their own accommodation arrangements. Hotel(s) close to the University/course venue include:

Hotel Alma169 University Gate NW Calgary, AB T2N 1N4Phone 403.220.2588Toll Free 1.877.498.3203Email [email protected]

To obtain a University rate, please indicate the promotion code UOFC and show your CME&PD course confirmation/receipt upon arrival.

COURSE OVERVIEW

This course provides evidence-based information about the pharmacology, methods of ingestion, adverse effects across the lifespan, medical uses of cannabis and effects on driving. Participants will learn about the diagnosis and treatment of medical emergencies involving cannabis and how to screen patients for cannabis use and for cannabis use disorder. Also covered are how to determine whether patients have contraindications for cannabis use, and the process for authorizing cannabis for medical purposes in appropriate patients.

COURSE OBJECTIVES

At the end of this course, learners will be equipped to:• summarize basic information about the pharmacology, methods of ingestion and adverse

effects of cannabis and its analogues• discuss the evidence supporting the use of cannabis for medical purposes• describe the types of cannabis related medical emergencies and their treatment• discuss the effects of cannabis on driving• discuss the effects of cannabis throughout the life span• counsel patients on cannabis use• screen patients for cannabis use disorder and identify appropriate treatment• discuss Alberta Health Services policies around cannabis use in hospital and homecare settings

WHO SHOULD ATTEND

Physicians, Pharmacists, Nurse Practitioners, Registered Nurses, Psychologists, Social Workers, Other Health Professionals, Residents and Trainees

CREDITS

Mainpro+ Group Learning – 6.75 credits | MOC Section 1 – 6.75 hours

The Canadian Council on Continuing Education in Pharmacy has accredited this program for 6.91 CEUs. Pharmacists Program Number: 1180-2018-2635-C-P, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Pharmacy Technicians Program Number: 1180-2018-2636-C-T, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25.

Practical Skills for Working with Patients Around CannabisCALGARY THERAPEUTICS PRE-COURSE

CANNABIS UPDATE 2019

Wednesday, April 24, 2019Red & White Club, 1833 Crowchild Trail NW, Calgary, AB

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 1 OF 9

CUMMING SCHOOL OF MEDICINE Office of Continuing Medical Education and Professional Development

V.19

Wednesday, April 24

0630-0800 Registration / Light Breakfast

0700-0745 PRE-COURSE PLENARY Cannabis 101 – Lori Montgomery

• describe cannabis pharmacology in terms patients can understand

• outline the major adverse effects of cannabis

• explain to a patient how different routes of dosing affect their response to cannabis

This session is intended for those with limited baseline knowledge of cannabis. Content in this presentation was covered at previous Cannabis Updates in 2017 and 2018.

0745-0800 Break

0800-0815 Opening Remarks – Barry Baylis, Lori Montgomery

0815-0900 PLENARY Cannabis in the Emergency Department – Eddy Lang

• discuss the Alberta data regarding cannabis related presentations to emergency departments

• describe the characteristics of cannabis related emergencies (psychosis, prolonged QT, hyperemesis) and basic treatment approaches

• discuss the “lessons learned” from cannabis related ED presentations in other jurisdictions

• counsel patients about the adverse effects of cannabis

0900-0945 PLENARY The Highs and Lows of Medical Cannabis – Tina Korownyk

• list known uses for cannabis for medical purposes for which there is evidence

• discuss any updates in the literature on evidence-based medical uses for cannabis

• refer to published guidelines on cannabis for medical use to provide guidance for patient use

• counsel patients on whether cannabis is an appropriate treatment for their medical needs

0945-1000 Nutrition Break

1000-1045 PLENARY

PART 1 – A Synthesis of Cannabis and Driving Research

– Jeff Caird

• synthesize research on crash risk and driving performance in drivers who have consumed cannabis

• provide practical guidance on medical and recreational cannabis use and driving

PART 2 – Update on Driving and Cannabis Use – Len Stefaniuk

• describe the roadside process for screening for impairment

• summarize the local experience with enforcement since the legalization of cannabis

• discuss the impact of recent changes in alcohol screening processes on screening drivers for cannabis use

1045-1105 SHORT SNAPPER Synthetic Cannabinoid Analogues –

New Designer Drugs – Barry Baylis

• list the most common illicit synthetic cannabinoid analogues

• describe the pharmacology of synthetics in comparison with endogenous and exogenous cannabinoids

• describe the presentations in the emergency department of patients who use these analogues

• discuss the treatment of patients who suffer from acute adverse effects of these analogues

1 105-1110 RESEARCH UPDATE Survey of the Perceived Benefits and Adverse

Effects of Cannabis Usage in Canadian Youth – Christine Ashenhurst, Vivian Hill, John Huang,

Emi Sanders

• recognize the perceptions of Canadian adolescents pre-legalization in a unique survey

• review possible areas for further study

COURSE PROGRAM

PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 2 OF 9

V.19

COURSE PROGRAM

PROGRAM MAY CHANGE DUE TO CIRCUMSTANCES BEYOND OUR CONTROL

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 3 OF 9

1110-1210 KEYNOTE Cannabinoids and Development of the Brain – Diana Dow Edwards

• summarize the effects of legalization on the epidemiology of cannabis use

• describe the prenatal effects of maternal cannabis use on child development

• describe the effects of adolescent cannabis use on cognition, mental health and substance abuse

1210-1305 Lunch

1305-1335 SHORT SNAPPER Assessing a Patient for Medical Cannabis –

To Authorize or Not to Authorize – Lydia Hatcher

• describe how to make informed decisions about whether a patient is a candidate for the use of medical cannabis

• use of validated tools to help screen for cautions and contraindications

1335-1345 Move to Workshops 1-3

1345-1445 CONCURRENT WORKSHOPS 1-3

1 How to Authorize Cannabis for Your Patient – Lydia Hatcher

• counsel a patient on how to choose a licensed producer

• complete the form to authorize cannabis following the College of Physicians and Surgeons of Alberta standard of practice

• counsel a patient regarding type of cannabis product (percentage THC, CBD or both), amount and method of ingestion

2 Screening for Cannabis Use Disorder and the Next Steps

– Monty Ghosh• choose an appropriate screening tool to

screen patients for cannabis use disorder

• screen and diagnose patients for cannabis use disorder

• describe appropriate treatment options for patients with cannabis use disorder

3 Balancing Patient-centred Care and Healthcare Provider Safety

– Michelle Kilborn• summarize the AHS patient cannabis use

policies in AHS facilities and in the community (homecare) settings

• outline the level of risk faced by providers whose patients use cannabis in their presence

• discuss the balance of patient-centred care and healthcare provider safety

1445-1455 Nutrition Break / Move to Workshops 4-6

1455-1555 CONCURRENT WORKSHOPS 4-6

4 Cannabis and the Cardiovascular System – Michael Slawnych

• indicate the risks of cannabis use for patients with cardiovascular disease

• describe the level of evidence for benefit in patients with cardiovascular disease

• discuss case studies of patients with cardiovascular disease who are using or want to use cannabis and counsel them about cannabis use

5 Assessing Older Adults for Cannabis Use – Lori Montgomery, Jim Silvius

• describe the implications of cannabis use with increasing age

• develop an approach to counselling the older patient and their families regarding cannabis use

• discuss case studies involving older adults and whether cannabis use is appropriate

6 Use of Cannabis in Palliative Care – Rizwan Qureshi

• indicate when cannabis is of use for symptom control in patients in palliative care (e.g. appetite, pain relief)

• discuss the risk assessment of patients in a palliative context and the use of cannabis

1555 Adjournment

V.19

PLANNING COMMITTEE

Barry Baylis MD FRCPC Course Co-Chair Clinical Associate Professor, Department of Medicine, Cumming School of Medicine, University of Calgary

Lori Montgomery MD CCFP Course Co-Chair Clinical Associate Professor, Department of Family Medicine and Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary; Medical Leader, Chronic Pain Centre, Alberta Health Services, Calgary Zone

Elwyn Brown MD CCFP Family Physician, Calgary

Michelle Gibbens BSW MSW Manager, Implementation Support – Western Canada, CADTH

Ruth-Ann Gingrich BScPharm MSc CSPI Community Pharmacist, Shoppers Drug Mart, Calgary; Pharmacist, PADIS

Jerry Hanen BScPharm Pharmacist, Alberta Health Services

John Huang MD FRCSC Clinical Associate Professor, Department of Surgery, Cumming School of Medicine, University of Calgary

Maria James BSP Clinical Pharmacist, Calgary Co-op, Calgary

Marsha Kucera MD CCFP Clinical Lecturer, Cumming School of Medicine, University of Calgary; Family Physician, Sunridge Medical Clinic, Calgary

Kathy Lee BScPharm Pharm D Pharmacist, PADIS

Lisa Lix BScPharm Community Pharmacist, Black Diamond

Ashi Mehta BSc MSc MD Project Manager, Physician Learning Program, University of Calgary

Sheldon Roth PhD BSc MSc Professor Emeritus, Cumming School of Medicine, University of Calgary

Cheryl Sadowski BSc (Pharm) PharmD BCGP FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta

Rhonda Shkrobot BScPharm ACPR Interim Alberta Liaison Officer, Implementation Support & Knowledge Mobilization; CADTH

Karen Then RN CCN(C) ACNP PhD Professor, Faculty of Nursing, University of Calgary

Diane Simpson PhD MDE CME Representative Education Consultant, Office of Continuing Medical Education and Professional Development, University of Calgary

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 4 OF 9

V.19

FACULTY

Barry Baylis MD FRCPC Course Co-Chair Clinical Associate Professor, Department of Medicine, Cumming School of Medicine, University of Calgary

Lori Montgomery MD CCFP Course Co-Chair Clinical Associate Professor, Department of Family Medicine and Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary; Medical Leader, Chronic Pain Centre, Alberta Health Services, Calgary Zone

Christine Ashenhurst Grade 11 Student, West Island College, Calgary

Jeff Caird PhD Professor, Departments of Psychology and Community Health Sciences, University of Calgary

Diana Dow Edwards PhD Professor of Physiology & Pharmacology, State University of New York

Monty Ghosh BSc MBT MSc MD FRCPC DM-EMDM ISAM(C) Internal Medicine and Addiction Medicine, Department of General Internal Medicine, University of Alberta; Internal Medicine Specialist, The Alex, Calgary

Lydia Hatcher MD CCFP FCFP CHE D-CAPM Associate Clinical Professor, Department of Family Medicine, McMaster University

Vivian Hill MD FRCPC Clinical Assistant Professor, Department of Surgery, University of Calgary; Pediatric Ophthalmologist, Private Practice, Calgary

John Huang MD FRCPC Clinical Associate Professor, Department of Surgery, Cumming School of Medicine, University of Calgary

Michelle Kilborn PhD AHS Cannabis Project Coordinator, Population, Public and Indigenous Health, Alberta Health Services

Tina Korownyk MD CCFP Associate Professor, Department of Family Medicine, Faculty of Medicine & Dentistry, University of Alberta; Assistant Director, Evidence and CPD, Alberta College of Family Physicians

Eddy Lang MDCM CCFP (EM) CSPQ Professor, Emergency Medicine, University of Calgary; Clinical and Academic Department Head for Emergency Medicine, Cumming School of Medicine, Alberta Health Services, Calgary Zone

Rizwan Qureshi MD Clinical Associate, Tom Baker Cancer Centre, Alberta Health Services

Emi Sanders BSc AHS Researcher / Clinical Admin

Jim Silvius FRCPC SPEC COMP Clinical Associate Professor, Department of Medicine, University of Calgary; Provincial Medical Director, Community Seniors Addiction & Mental Health; Senior Medical Director, Seniors Health Strategic Clinical Network

Michael Slawnych MD FRCPC Clinical Assistant Professor, Cardiac Sciences, Department of Medicine, Cumming School of Medicine, University of Calgary

Len Stefaniuk CPS Alcohol and Drug Recognition Unit (ADRU), Calgary Police Service, Traffic Section

DISCLOSURE OF POTENTIAL FINANCIAL CONFLICTS OF INTEREST

In keeping with accreditation guidelines, speakers participating in this event have been asked to disclose to the audience any involvement with industry or other organizations that may potentially influence the presentation of the educational material. Disclosure will be done verbally and using a slide prior to the speaker’s presentation.

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 5 OF 9

V.19

ACCREDITATION

STUDY CREDITS

The University of Calgary – Office of Continuing Medical Education and Professional Development is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME).

CFPC

MAINPRO+ GROUP LEARNING

This one-credit-per-hour Group Learning program meets the certification criteria of The College of Family Physicians of Canada and has been certified by the University of Calgary Office of Continuing Medical Education and Professional Development for up to 6.75 Mainpro+ credits.

AACP

AMERICAN ACADEMY OF FAMILY PHYSICIANS (AAFP) AND CFPC

Members of the American Academy of Family Physicians are eligible to receive up to 6.75 prescribed credits for attendance at this meeting/event due to a reciprocal agreement with The College of Family Physicians of Canada.

RCPSC

MOC SECTION 1

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 6.75 hours (credits are automatically calculated).

AMA-PRA CATEGORY 1 CREDIT

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. More information on the process to convert Royal College MOC credit to AMA credit at https://www.ama-assn.org/education/earn-credit-participation-international-activities.

Read more on the Royal College agreement with the American Medical Association at http://www.royalcollege.ca/rcsite/cpd/providers/international-accreditation-agreements-e.

PHARMACISTS

CANADIAN COUNCIL ON CONTINUING EDUCATION IN PHARMACY

The Canadian Council on Continuing Education in Pharmacy has accredited this program for 6.91 CEUs. Pharmacists Program Number: 1180-2018-2635-C-P, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25. Pharmacy Technicians Program Number: 1180-2018-2636-C-T, Accreditation Date: 2019-04-24, Accreditation Expiry Date: 2019-04-25.

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 6 OF 9

V.19

ADDITIONAL PROGRAM INFORMATION

DRESS

Dress is business casual. Sweaters or items of clothing that can be layered are recommended since temperature in the venue may fluctuate.

MEALS

In general, each course offers a light breakfast, nutrition break(s) and lunch. We are sensitive to dietary requirements (for example, gluten free, peanut allergies) and do our best to offer a variety of options; however we are unable to guarantee that all dietary needs can be accommodated.

SCENT FREE

To ensure the comfort of everyone attending this event, please do not wear scented products.

CONFIRMATION OF REGISTRATION

Confirmation will be sent by email to registrants.

COURSE CANCELLATION POLICY

The Office of Continuing Medical Education and Professional Development reserves the right to cancel the course if there are insufficient registrations.

REFUND POLICY

A registration refund will be made upon written request if made at least two weeks before the start of the program; however $50 will be retained for administrative costs. No refunds will be available for cancellations made within two weeks of the start of the program and thereafter.

REIMBURSEMENT OF REGISTRATION FEES

Physicians may be eligible for reimbursement of registration fees and expenses to attend CME courses from a fund administered by the Alberta Medical Association. For more information regarding this, please call the AMA at 780.482.2626 or 1.800.272.9680.

FOR FURTHER INFORMATION

Office of Continuing Medical Education and Professional Development, Cumming School of Medicine, University of Calgary, TRW Building, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6

ABOUT COURSE CONTENT

Diane Simpson, Education Consultant Phone 403.210.8804 Email [email protected]

Dana Young, Education Coordinator Phone 403.210.6226 Email [email protected]

ABOUT GENERAL PROGRAM INFORMATION

Monica Rast, Program Assistant Phone 403.220.6493 Email [email protected]

ABOUT REGISTRATION

Phone 403.220.7032 Email [email protected]

cumming.ucalgary.ca/cme

CANNABIS UPDATE 2019 | PAGE 7 OF 9

V.19

REGISTRATION FEEPLUS 5% GST – UCalgary GST Registration #108102864RT0001ADD 5% TO FEE(S) BELOW TO CALCULATE TOTAL COURSE FEE

EARLY RATE on or before March 19, 2019

$ 295.00 Physician

$ 295.00 Other Health Professional

$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)

REGULAR RATE after March 19, 2019

$ 350.00 Physician

$ 350.00 Other Health Professional

$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)

ON-SITE RATE (Based on availability and not guaranteed)

$ 420.00 Physician

$ 420.00 Other Health Professional

$ 150.00 Student / Resident (FULL-TIME STUDENTS ONLY)

Cannabis Update 2019 April 24, 2019

COURSE # – 10021692-30006

FIRST NAME

EXPIRY DATE

LAST NAME

ADDRESS

CITY

AREA CODE PHONE AREA CODE FAX

EMAIL

CHEQ M YM Y

SIGNATURE

AMEX VISA MASTERCARD

CARD NUMBER

PROVINCE POSTAL CODE

EXT

REGISTER

ONLINEcumming.ucalgary.ca/cme

BY CONFIDENTIAL FAXFax 403.270.2330

For your protection, the University of Calgary does not accept and will not process credit card information provided via email or text messages

BY MAILCheque Payable – UNIVERSITY OF CALGARY

CHEQUE MUST INCLUDE 5% GST

Cumming School of Medicine, Office of Continuing Medical Education and Professional Development, University of Calgary, TRW Building, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6

REGISTRATION SERVICESPhone 403.220.7032 Email [email protected]

REGISTRATION FORM

cumming.ucalgary.ca/cme

FREEDOM OF INFORMATION AND PROTECTION OF PRIVACY ACT Registration information is collected under the authority of the Freedom of Information and Protection of Privacy Act. The contact information you provide is required by our Office to register you in the course, prepare material and courses for your use, plan for future courses and notify you of similar, upcoming courses offered by our Office. Financial information is used to process applicable fees and is retained for future reference. Call 403.220.4251 if you have questions about the collection or use of this information.

CANNABIS UPDATE 2019 | PAGE 8 OF 9

PAYMENT BY COMPLETE REGISTRATION FORM Part 2 >>

Part 1PROFESSION

COMMUNITY SIZE IN WHICH YOU PRACTICE

YEARS OF PRACTICE – PLEASE SPECIFY

GREATER THAN 1,000,000 INHABITANTS

15,001-999,999 INHABITANTS

0-15,000 INHABITANTS

FAMILY PHYSICIAN NURSE PRACTITIONER

SPECIALIST PHYSICIAN – PLEASE SPECIFY OTHER HEALTH PROFESSIONAL – PLEASE SPECIFY

PHARMACIST STUDENT/RESIDENT (FULL-TIME STUDENTS ONLY)

UCID(IF APPLICABLE)

DATE OF BIRTHM DM D

V.19

Cannabis Update 2019 April 24, 2019

REGISTRATION FORM

FIRST NAME

LAST NAME

Part 2

CONCURRENT WORKSHOPS SELECTIONS

cumming.ucalgary.ca/cme

Workshops 1-3 • 1345-1445 Select 3 – Number in order of preference with 1 being most important

1 How to Authorize Cannabis for Your Patient

2 Screening for Cannabis Use Disorder and the Next Steps

3 Balancing Patient-centred Care and Healthcare Provider Safety

Workshops 4-6 • 1455-1555 Select 3 – Number in order of preference with 1 being most important

4 Cannabis and the Cardiovascular System

5 Assessing Older Adults for Cannabis Use

6 Use of Cannabis in Palliative Care

CANNABIS UPDATE 2019 | PAGE 9 OF 9